HocusLocus Inc.
Biotech · Private
PTSelect, a post-transcriptional regulation platform using siRNA-intron coupling to improve cell line selection and protein yield in biopharmaceutical manufacturing
- Grants
- $3.8M
- 7 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201420152016201720182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · sxRNA-based Antiviral Approach targeting Epstein-Barr virus | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · sxRNA-based Antiviral Approach targeting Epstein-Barr virus | $225,000 | |
| Federal grant | National Science Foundation · Phase I · STTR Phase I: Improving Biomanufacturing in Chinese Hampster Ovary Cells Using Structurally Interacting RNA (sxRNA) | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · A Novel Approach to Purifying iPSC Derived Cell Cultures | $225,000 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · Improvements to Biopharmaceutical Manufacturing | $733,711 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · Improvements to Biopharmaceutical Manufacturing | $1,427,252 | |
| Federal grant | Department of Health and Human Services · Phase II · Improvements to Biopharmaceutical Manufacturing | $693,541 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3242 | SEVIVO, LLC | — | — |
| 3243 | Alchemab Therapeutics | — | — |
| 3244 | Abdera Therapeutics | — | — |
| 3245 | HocusLocus Inc. | — | — |
| 3246 | DORIAN THERAPEUTICS, INC. | — | — |
| 3247 | TARGEAD SCIENCES, INC. | — | — |
| 3248 | SYMBIOTICA, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.